338 related articles for article (PubMed ID: 1105663)
21. [Current status of immunotherapy of malignant tumors].
Flad HD; Betzler M; Herfarth C
Chirurg; 1979 Jan; 50(1):11-5. PubMed ID: 367730
[No Abstract] [Full Text] [Related]
22. Critical review of previously reported animal studies of tumor immunotherapy with nonspecific immunostimulants.
Bast RC; Bast BS
Ann N Y Acad Sci; 1976; 277(00):60-93. PubMed ID: 826208
[No Abstract] [Full Text] [Related]
23. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
[No Abstract] [Full Text] [Related]
24. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
[TBL] [Abstract][Full Text] [Related]
25. Antitumor activity of cell-wall skeleton of Propionibacterium acnes C7 in mice and guinea pigs.
Azuma I; Yamawaki M; Yoshimoto T; Saiki I; Uemiya M; Tanio Y; Tokuzen R; Yasumoto K; Yamamura Y
Gan; 1979 Dec; 70(6):737-48. PubMed ID: 395008
[TBL] [Abstract][Full Text] [Related]
26. Treatment of the mouse Lewis tumor by the association of radiotherapy and immunotherapy with Bacillus Calmette-Guérin.
Dubois JB; Serrou B
Cancer Res; 1976 May; 36(5):1731-4. PubMed ID: 773530
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy of malignancy in humans. Current status.
Holmes EC; Eilber FR; Morton DL
JAMA; 1975 Jun; 232(10):1052-5. PubMed ID: 236402
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapy in malignant melanomaa.
Homes EC; Morton DL; Eilber FR; Golub SE; Sulit HL
Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763
[TBL] [Abstract][Full Text] [Related]
29. Distant cutaneous granulomas after bacille Calmette-Guérin immunotherapy for malignant melanoma: case for direct infection.
Moff SL; Corey GR; Gottfredsson M
Clin Infect Dis; 1999 Dec; 29(6):1569-70. PubMed ID: 10585816
[No Abstract] [Full Text] [Related]
30. Differences in biological activity among batches of lyophilized tice Bacillus Calmette-Guérin and their association with clinical course in Stage I lung cancer.
Bennett JA; Gruft H; McKneally MF; Zelterman D; Crispen RG
Cancer Res; 1983 Sep; 43(9):4183-90. PubMed ID: 6347367
[TBL] [Abstract][Full Text] [Related]
31. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
Vaage J
Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
[TBL] [Abstract][Full Text] [Related]
32. The immunological aspects of malignant disease.
Oliver RT
Practitioner; 1975 Apr; 214(1282):511-521. PubMed ID: 49889
[No Abstract] [Full Text] [Related]
33. Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer.
Key ME; Brandhorst JS; Hanna MG
J Immunol; 1983 Jun; 130(6):2987-92. PubMed ID: 6304194
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy of malignancies: current status.
Eilber FR; Holmes EC; Morton DL; Ramming KP; Sparks FC
AJR Am J Roentgenol; 1976 May; 126(5):1088-93. PubMed ID: 178234
[TBL] [Abstract][Full Text] [Related]
35. L2C leukemia: a model of human acute leukemia.
Murphy SG; LoBuglio AF
Fed Proc; 1977 Aug; 36(9):2281-5. PubMed ID: 328309
[No Abstract] [Full Text] [Related]
36. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
[No Abstract] [Full Text] [Related]
37. Combined treatment of syngeneic murine tumors and xenotransplanted human lung cancer by immunotherapy and radiotherapy.
Terashima H; Yasumoto K; Yanagawa E; Takayama K; Nomoto K; Azuma I; Yamamura Y
Gan; 1981 Jun; 72(3):363-9. PubMed ID: 7033032
[TBL] [Abstract][Full Text] [Related]
38. Some immunologically based reactions that can cause the regression of large tumor masses.
Alexander P
Natl Cancer Inst Monogr; 1976 Nov; 44():105-8. PubMed ID: 799755
[TBL] [Abstract][Full Text] [Related]
39. Influence of preexisting tumor immunity on Bacillus Calmette-Guérin immunotherapy of guinea pigs with both regional and disseminated tumor.
Jessup JM; Riggs CW; Hanna MG
Cancer Res; 1977 Aug; 37(8 Pt 1):2565-73. PubMed ID: 872084
[No Abstract] [Full Text] [Related]
40. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
Nathanson L; Clark DA
Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]